Antidiabetic drugs could lower risk of primary and secondary brain cancer
University of BristolDiabetic patients who take anti-diabetic drugs - known as glitazones – long term had a lower risk of primary and secondary brain cancer compared with diabetic patients on other medications, new research led by the University of Bristol has found.